The US varicose vein treatment device market will be characterized by modest growth and a changing reimbursement landscape for new endovenous ablation technologies, which will compete with more…
The mature US CABG device market will contract slightly through 2026 as procedure volumes decline due to increasing use of PCI for the treatment of CAD; however, rising interest in off-pump and…
The US market for stroke devices will grow strongly through 2026 as a result of the adoption of innovative devices as well as the establishment of dedicated infrastructure for stroke treatment…
The Latin America varicose vein device market is greatly underpenetrated and will see strong growth driven by economic growth and health care investments; the endovenous ablation market is…
The Latin American varicose vein treatment device market will be characterized by low growth in minimally invasive procedures such as sclerotherapy and endovenous ablation technologies, which…